HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ligation-assisted endoscopic submucosal resection with apical mucosal incision to treat gastric subepithelial tumors originating from the muscularis propria.

AbstractBACKGROUND:
This study aimed to evaluate the clinical efficacy, safety, and feasibility of performing endoscopic submucosal resection with a ligation device (ESMR-L) after apical mucosal incision (AMI) for the treatment of gastric subepithelial tumors originating from the muscularis propria (SET-MPs).
METHODS:
14 patients with gastric SET-MPs were treated by ESMR-L with AMI between December 2016 and May 2017. The complete resection rate, operation duration, and postoperative complications were collected. All patients were followed for 2 - 6 months.
RESULTS:
The complete resection rate was 100 %, the mean tumor size was 10.71 ± 3.45 mm (7 - 18 mm), and the median operative time was 18.5 minutes. Perforation occurred in four patients, with all lesions being completely repaired endoscopically. No delayed bleeding or peritoneal signs were observed. No residual lesions or recurrence were found during the follow-up period.
CONCLUSIONS:
AMI with ESMR-L appears to be an efficient and simple method for the histological diagnosis of gastric SET-MPs, but it carries a high perforation rate and cannot guarantee cure.
AuthorsDingguo Zhang, Qiuling Lin, Ruiyue Shi, Lisheng Wang, Jun Yao, Yanhui Tian
JournalEndoscopy (Endoscopy) Vol. 50 Issue 12 Pg. 1180-1185 (12 2018) ISSN: 1438-8812 [Electronic] Germany
PMID29913532 (Publication Type: Journal Article, Video-Audio Media)
Copyright© Georg Thieme Verlag KG Stuttgart · New York.
Topics
  • Adult
  • Aged
  • Endoscopic Mucosal Resection (adverse effects, instrumentation, methods)
  • Female
  • Gastric Mucosa (surgery)
  • Humans
  • Ligation
  • Male
  • Middle Aged
  • Neoplasm, Residual
  • Operative Time
  • Retrospective Studies
  • Stomach Neoplasms (pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: